Chris Garabedian

Chris Garabedian is the current chairman at Bioharmony Therapeutics. Prior to this, they were the chairman of the board at Quellis Biosciences from November 2017 to January 2021. Before that, they were a senior advisor to healthcare practice at The Boston Consulting Group from January 2016 to December 2021. From January 2011 to March 2015, they were the chief executive officer at Sarepta Therapeutics.

Chris Garabedian has a B.S. in Marketing from the University of Maryland.